{'Year': '2021', 'Month': 'Dec', 'Day': '21'}
Frequency and clinical relevance of DPYD genetic variants in gastrointestinal cancer patients.
To determine the prevalence of loss-of-function variants in the dihydropyrimidine dehydrogenase gene in patients with gastrointestinal neoplasms, assess their clinical relevance, and evaluate the  implementation of a multidisciplinary circuit at three months from its  implementation.